Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

46results about How to "Effective colonization" patented technology

Water culture method of dwarf bamboo suitable for laboratory scientific research and culture device thereof

ActiveCN109329029AControl indoor cultivation environment parametersControlling Culture Environment ParametersAgriculture gas emission reductionCultivating equipmentsPhacusNutrient solution
The invention discloses a water culture method of dwarf bamboo suitable for laboratory scientific research and a culture device thereof. The culture device is firstly manufactured and comprises waterculture barrels, a fixing device and a ventilating device, wherein diluted working nutrient solution is added into each water culture barrel, dwarf bamboo plants required by the experiment are selected, the root system original soil is removed, the root system is washed by using clear water, the over ground part of the cleaned dwarf bamboo is fixed above a fixing device, the underground part is placed below the fixing device, the fixing device and the bamboo seedlings are placed into the water culture barrel together, and the bamboo seedlings are treated at the stage when the original soil culture root system is replaced and the new aquatic root system is induced, the bamboo seedlings are treated at the growth stage of the aquatic root system. The method and the device can achieve the water culture of the dwarf bamboo, and the whole transplanting process from the unearthed bamboo seedlings to the planting in the water culture device is beneficial to the material taking test of each organ of the dwarf bamboo, thereby expanding the wider scientific research application in a laboratory, the rhizomes can effectively absorb nutrients required by the plants.
Owner:SICHUAN AGRI UNIV

Application of bacteroides fragilis and zwitterionic capsular polysaccharide thereof in preparation of medicine for treating respiratory system tumors

The invention discloses an application of Bacteroides fragilis and/or zwitterionic capsular polysaccharide thereof in preparation of a medicine for treating respiratory system tumors, the Bacteroides fragilis, especially the Bacteroides fragilis ZY-312 with the preservation number of CGMCC No.10685 and the zwitterionic capsular polysaccharide thereof, can be used for preparing medicines for treating respiratory system tumors by increasing the levels of anti-tumor factors IL-12 and IFN-gamma, and can be used for preparing medicines for treating respiratory system tumors. The traditional Chinese medicine composition can be used for inhibiting expression of a tumor promoting factor IL-1beta, promoting up-regulation of the proportion of infiltrated CD8 + CD45 + T cells in tumors, regulating the microenvironment of tumor tissues, reducing the weight of in-situ tumors and inhibiting the number of tumor metastases, can be used for effectively preventing and treating respiratory system tumors, can be independently used for cancer treatment, and also can be used for preventing and treating tumors. The traditional Chinese medicine composition can also be combined with other treatment means such as microorganisms, operations, radiotherapy and chemotherapy, so that the comprehensive curative effect is remarkably improved, the harm of radiotherapy and chemotherapy to organisms is relieved, occurrence, development, relapse and metastasis of respiratory system tumors are effectively prevented, and the living quality of patients is improved.
Owner:GUANGZHOU ZHIYI PHARMA INC

Application of combination of bacteroides fragilis and immune checkpoint inhibitor in treatment of digestive system tumors

PendingCN114392356AImprove comprehensive curative effectReduce body damageUnknown materialsAntibody ingredientsBacillus fragilisImmune checkpoint inhibitors
The invention discloses an application of a combination of bacteroides fragilis and an immune checkpoint inhibitor in treatment of digestive system tumors, and particularly relates to a combination of bacteroides fragilis ZY-312 with the preservation number of CGMCC No.10685, inactivated bacteria of the bacteroides fragilis ZY-312 and the immune checkpoint inhibitor including a PD-1 antibody or a PD-L1 antibody, and the bacteroides fragilis ZY-312, the inactivated bacteria of the bacteroides fragilis ZY-312 and the immune checkpoint inhibitor including the PD-1 antibody or the PD-L1 antibody can be combined in vivo by increasing the proportion of CD4 + T cells and CD8 + T cells. By down-regulating the level of cell factors IL-10 in tumors or up-regulating the level of INF-gamma, the growth of transplanted tumors in mice can be effectively inhibited. The traditional Chinese medicine composition can also be combined with treatment means such as operation, radiotherapy and chemotherapy, so that the comprehensive curative effect is remarkably improved, the harm of radiotherapy and chemotherapy to the body is relieved, occurrence, development, relapse and metastasis of tumors are effectively prevented, and the living quality of patients is improved.
Owner:GUANGZHOU ZHIYI PHARMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products